It seems like there’s still chaos inside the FDA’s biologics branch CBER led by Vinay Prasad. As many of you will remember, Prasad was forced out shortly after becoming CBER Director earlier this year. Then Makary and RFK Jr. pushed successfully to bring him back. Since then apparently things have not been great between Prasad […]
The post Recommended reads: Valentina Greco, CRISPR trials halted on safety, JAX acquisition, Prasad vs. CBER appeared first on The Niche.